Next Day Disclosure Returns - [Share Buyback]

CARsgen is a leading immunotherapy company focused on the development of new chimeric antigen receptor T (CAR-T) cell therapeutics for liver, lung, stomach and brain cancers. The company has relationships with Shanghai Cancer Institute and Shanghai Renji Hospital, plans to initiate clinical trials for KJgpc3-001, a glypican-3 (GPC3)-directed CAR-T cell therapy.

Next Day Disclosure Return

Announcements and Notices - [Other - Miscellaneous]

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

CARSgen Therapeutics (2171 HK)

Next Day Disclosure Return

Voluntary Announcement - Shareholding Increase By The Substantial Shareholder And Share Repurchase By The Company

Next Day Disclosure Return

Next Day Disclosure Return

Next Day Disclosure Return

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)